Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced a new strategic alignment to prioritize and ...

Following a successful End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) announced in March 2026, the Phase 3 program for BPL-003 in TRD remains on track for initiation in ...

NORTH BETHESDA, Md., March 17, 2026 /PRNewswire/ -- The International Society for Pharmaceutical Engineering (ISPE) has announced its keynote speakers for the 2026 ISPE Europe Annual Conference, ...

Military medical teams of Vietnam and China on Tuesday provided medical examinations and treatment for residents in Hoanh Mo commune in Vietnam’s Quang Ninh province and in Dongzhong Town in China’s ...

With the mayor’s focus on data and planning, there are many documents being produced for Council meetings and for posting on ...

Seasoned leader brings more than 30 years of medical device experience, with a proven track record of growing revenue, earnings, and cash flow across multiple publicly traded healthcare companies ...

Total revenue of $41.8 million in Q4 2025, up 86% as reported and 23% on an adjusted pro forma basis versus Q4 2024 Greenbrook clinic revenue of $23.5 million in Q4 2025, up 428% as reported and 37% ...

WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on ...

Throughout the year, the Company reported significant positive preclinical findings for SIL204 across eight KRAS mutations and four cancer types, ...

Detailed price information for Quantum Emotion Corp (QNC-X) from The Globe and Mail including charting and trades.